A retrospective observational study on characteristics, treatment patterns, and healthcare resource use of patients with xerostomia in primary care settings using Optimum Patient Care Research Database in United Kingdom.

Study identification

• EU PAS number:
  EUPAS44384
• Study ID:
  48502
• Official title and acronym:
  A retrospective observational study on characteristics, treatment patterns, and healthcare resource use of patients with xerostomia in primary care settings using Optimum Patient Care Research Database in United Kingdom.
• DARWIN EU® study:
  No
• Study countries:
  United Kingdom
• Study description:
  The general aim of the study is to gain a better understanding of the xerostomia patients, in terms of their characteristics, treatment patterns, and burden in primary care including primary healthcare resource use and associated costs. The objectives of the study are: Primary objective • To describe patients newly diagnosed with xerostomia in terms of their socio-demographic characteristics, comorbidities, and treatments susceptible to cause xerostomia prior to index date. Secondary objectives • To describe treatment for xerostomia and associated costs, post-index date. • To describe primary healthcare resource use and associated costs, pre- and post-index date in patients with xerostomia.
• Study status:
  Finalised

Research institutions and networks

Institutions

OPEN Health

Study timelines

Date when funding contract was signed

Actual:12/10/2021

Study start date

Planned:29/07/2022

Actual:01/08/2022

Data analysis start date

Planned:29/07/2022

Actual:08/08/2022

Date of final study report

Planned:30/09/2022

Actual:08/11/2022

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Colgate Palmolive

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable